: A A

Under the 2011 US-China Trade and Economic Cooperation Forum, American Oriental Bioengineering, Inc. signs with Palm Beach CRO for American Pharmaceutical Clinical Trials

Thu, Feb 10, 2011

Clinical News Room

February 2, 2011

Palm Beach Clinical Research Organization (PBCRO), a clinical research organization located in West Palm Beach, Florida, USA, has been selected by American Oriental Bioengineering, Inc. (NYSE: AOB) to conduct American clinical trials of AOBO-developed pharmaceuticals. The partnership was formalized on January 21, 2011 at the historic US-China Trade and Economic Cooperation Forum held in Chicago, Illinois, USA.

AOBO was the only Chinese pharmaceutical company among the Chinese delegation of approximately 60 companies signing agreements with American firms.

Palm Beach CRO is the only American clinical research organization to have participated in this trade agreement.

The announcement comes in the wake of Chinese President Hu Jintao’s official state visit to the United States and the Chinese delegation’s participation at the January 21st Forum, which featured addresses by US Secretary of Commerce Gary Locke, Chinese Commerce Minister Chen Deming, and Vice Minister Wang Chao. AOBO was represented at the Forum by its Chairman and CEO, Tony Liu, and other senior executives.

Palm Beach CRO was represented at the Forum by its President, Arthur Simon, Ph.D., Chief Financial Officer, Audrey Haber, Ph.D., and CEO, David Scott, MBA.

“Palm Beach CRO has a long-standing reputation for its pro-active approach in working with pharmaceutical sponsors to get their clinical trials up and running,” says PBCRO president Simon. “This is why we believe we were successful in winning this research contract with American Oriental Bioengineering, Inc.”

“On behalf of our CEO, Tony Liu, and all members of AOBO-001 technical team, I would like to express my appreciation for Palm Beach CRO’s technical contributions, support and efforts,” said Tom Du, M.D., Ph.D., AOBO’s Chief Technology Officer. “We believe we have selected the best team for our study among other CROs and are looking forward to working with Palm Beach CRO on this project for the next few years.”

Services provided by Palm Beach CRO (www.PalmBeachCRO.com) run the gamut from site evaluation, protocol preparation and site documentation to site closeout and data management and analysis.

American Oriental Bioengineering, Inc. (www.bioaobo.com) is an international pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over-the-counter products. It has research and operations centers in China and the United States.

Comments are closed.